Zymeworks

ZYME • NASDAQ • Stock Fundamentals

Zymeworks is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Kenneth H. Galbraith, with a market cap of $1.7B.

Market Cap$1.7B

Employees275.0

CEOKenneth H. Galbraith

CountryCanada

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Zymeworks

Zymeworks (ZYME) has a market capitalization of $1.7B and trades on NASDAQ.

Zymeworks has approximately 275 employees.